Clover Health releases transcript of 1Q26 earnings call
Clover Health
Clover Health CLOV | 0.00 |
- Clover Health Investments Corp. discussed 1Q26 results on its earnings call attended by CEO Andrew Toy, interim CFO Clay Thornton, and investor relations head Ryan Schmidt.
- GAAP net income reached $27 million as Medicare Advantage membership rose 51% year over year to about 156,000, lifting total revenue 62% to $749 million.
- Management pointed to best-in-class retention, stable benefit design, and moderated in-year enrollment to prioritize clinical integration, while calling Clover largest PPO in New Jersey outside SNP and employer retiree plans.
- Insurance BER was 86.5%; inpatient utilization fell year over year, outpatient costs stayed elevated but tracked expectations, dental cost actions reduced out-of-network variability, and Part D trended in line with expectations in year two of IRA changes.
- Outlook stayed intact with expectation to meet or exceed full-year targets; management flagged monitoring of outpatient and Part D pressure, said 2027 bids were premature to detail, and cited minimal expected impact from unlinked chart review changes due to encounter-based documentation and CMS switcher exception.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clover Health Investments Corp. published the original content used to generate this news brief on May 07, 2026, and is solely responsible for the information contained therein.
